Featured · metabolic
Retatrutide: The Next-Generation GLP-1 Research Peptide (2026 Update)
TL;DR — The landscape of metabolic research has shifted dramatically in the past 24 months. While semaglutide and tirzepatide dominated early GLP-1 research, a new class of compound has emerged with the potential to reshape how researchers appro…
Retatrutide combines GLP-1, GIP, and glucagon receptor agonism in a single molecule. What research has revealed through 2026, and why this triple agonist is redefining metabolic research.
August 6, 2026 · 6 min